BSX
Beyond's analysis on BSX
- — TD Cowen maintains its Buy rating on Boston Scientific, signaling continued confidence in the medtech giant's growth prospects
- — Boston Scientific emerges as a promising investment opportunity in the healthcare sector
Recent news mentioning BSX
- — How Much Upside Can BSX Stock's Growth Deliver?
- — Has BSX Stock Fallen Far Enough To Buy?
- — Time To Squeeze 14% Yield Out Of Battered BSX Stock?
- — The Floor Under BSX Stock Is Being Tested Again
- — Boston Scientific (BSX) Faces Growth Concerns in Key Medical Device Franchises
- — Boston Scientific (BSX) Faces Growth Slowdown in Key Businesses
- — Here’s What Hurt Boston Scientific Corporation (BSX) in Q2
- — Boston Scientific Director Habiger Buys $100k of Shares Amid 54% Decline. What Does This Mean for BSX in 2026?